HERTX
Price
$9.63
Change
-$0.15 (-1.53%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

HERTX vs RNWFX

Header iconHERTX vs RNWFX Comparison
Open Charts HERTX vs RNWFXBanner chart's image
Hartford Emerging Markets Equity R5
Price$9.63
Change-$0.15 (-1.53%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HERTX vs RNWFX Comparison Chart
Loading...
VS
HERTX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HERTX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. HERTX (354M). HERTX pays higher dividends than RNWFX: HERTX (3.70) vs RNWFX (1.51). HERTX was incepted earlier than RNWFX: HERTX (13 years) vs RNWFX (22 years). HERTX is a more actively managed with annual turnover of: 93.00 vs. RNWFX (32.00). HERTX has a lower initial minimum investment than RNWFX: HERTX (0) vs RNWFX (250). HERTX annual gain was more profitable for investors over the last year : 16.50 vs. RNWFX (11.53). HERTX return over 5 years is better than : 27.21 vs. RNWFX (22.38).
HERTXRNWFXHERTX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD10.6337.245147%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets354M60.1B1%
Annual Yield % from dividends3.701.51246%
Returns for 1 year16.5011.53143%
Returns for 3 years-4.24-15.4427%
Returns for 5 years27.2122.38122%
Returns for 10 years16.3735.7146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio